SYDNEY – November 02, 2026 -- Kazia Therapeutics (NASDAQ: KZIA) will present two preclinical abstracts on its lead asset paxalisib at the San Antonio Breast Cancer Symposium (SABCS), held Dec. 8-11, 2026, in San Antonio, Texas.

SYDNEY – October 29, 2026 -- Kazia Therapeutics (NASDAQ: KZIA) will put its CEO and its head of corporate strategy in front of investors at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 9, 2026, at 8:30 a.m. EST.